Jeffrey Berkowitz

Jeffrey Berkowitz

Directeur/Membre du Conseil chez BRAEBURN INC.

Fortune : 577 173 $ au 31/05/2026

60 ans
Health Technology
Commercial Services
Health Services

Profil

Jeffrey Berkowitz is currently Chief Executive Officer & Director at Real Endpoints LLC since 2018.
He is Chairman at Pharma Two B Ltd. since 2021.
He serves as Independent Director at H.
Lundbeck A since 2018.
He is Director at Click Therapeutics, Inc. and Braeburn, Inc. since 2017.
He is Senior Adviser at Permira Advisers LLP since 2023.
He is also a Venture Advisor at Israel Biotech Fund.
Former roles include Independent Director at Esperion Therapeutics, Inc. from 2017 to 2023, Independent Director at Infinity Pharmaceuticals, Inc. from 2014 to 2020, Director at Swiss-American Chamber of Commerce, Director at Aptus Health, Inc. from 2010 to 2013, Director at ZappRx, Inc. from 2016 to 2018, Independent Non-Executive Director at Uniphar Plc from 2020 to 2024, Independent Director at Zealand Pharma A from 2019 to 2026, Senior Vice President-Global Market Access at Merck & Co., Inc. from 2009 to 2010, Vice President-Global Market Access at Schering-Plough Corp., Executive Vice President at UnitedHealth Group, Inc. from 2016 to 2017, SVP-Pharmaceutical Development & Market Access at Walgreen Co. from 2010 to 2013, Attorney at Proskauer Rose LLP, Executive Vice President at InGensa, Inc. from 2016 to 2017, EVP, President-Pharma & Global Market Access at Walgreens Boots Alliance, Inc. from 2010 to 2015, Co-President at Walgreens Boots Alliance Development GmbH from 2013 to 2014, and Executive Vice President at Optum, Inc. Education includes undergraduate studies at Union College (New York) and graduate studies at Brooklyn Law School.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/12/2025 11 377 ( 0,02 % ) 577 173 $ 31/05/2026

Postes actifs de Jeffrey Berkowitz

SociétésPosteDébut
H. LUNDBECK A/S Directeur/Membre du Conseil 20/03/2018
BRAEBURN INC. Directeur/Membre du Conseil 01/12/2017
Consultant / Advisor -
Directeur/Membre du Conseil -
Président 12/08/2021
Directeur Général 13/09/2018
Consultant / Advisor 08/11/2023

Anciens postes connus de Jeffrey Berkowitz

SociétésPosteFin
ZEALAND PHARMA A/S Directeur/Membre du Conseil 26/03/2026
UNIPHAR PLC Directeur/Membre du Conseil 16/01/2024
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Jeffrey Berkowitz

Formation de Jeffrey Berkowitz

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

58

Relations au 1er degré

25

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées25

Health Technology

Health Technology

Health Services

Retail Trade

Health Technology

Health Technology

Technology Services

Finance

Commercial Services

Health Technology

Consumer Services

Health Technology

Consumer Services

Commercial Services

Commercial Services

Commercial Services

Technology Services

Health Technology

Commercial Services

Retail Trade

Distribution Services

Health Technology

Finance

Commercial Services

Health Services

  1. Bourse
  2. Insiders
  3. Jeffrey Berkowitz
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇